# Liothyronine Sodium

NDC: 42794-019
Generic name: Liothyronine Sodium
Labeler / Manufacturer: SIGMAPHARM LABORATORIES, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20121203

FDA application: ANDA200295

## Active ingredients

- LIOTHYRONINE SODIUM: 25 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42794-019"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42794-019
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=38ef3766-bb9a-402e-9e4a-ad8bb5b26e4c